dmelna45
2022-05-05
$瑞科生物-B(02179)$
除了mRNA,还需要关注的是重组蛋白领域,谁能在抗原层面做的更好,并且可以联合新佐剂,尤其是自主研发的新佐剂,这样的公司是我们应该长期为伍的。
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":616696275,"tweetId":"616696275","gmtCreate":1651721673340,"gmtModify":1651721673340,"author":{"id":3570162176951843,"idStr":"3570162176951843","authorId":3570162176951843,"authorIdStr":"3570162176951843","name":"dmelna45","avatar":"https://static.tigerbbs.com/f5f07094f48eceb5b0e70bdd5ed5b4a1","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n<a target=\"_blank\" href=\"https://laohu8.com/S/02179\">$瑞科生物-B(02179)$</a>除了mRNA,还需要关注的是重组蛋白领域,谁能在抗原层面做的更好,并且可以联合新佐剂,尤其是自主研发的新佐剂,这样的公司是我们应该长期为伍的。</body></html>","htmlText":"<html><head></head><body>\n<a target=\"_blank\" href=\"https://laohu8.com/S/02179\">$瑞科生物-B(02179)$</a>除了mRNA,还需要关注的是重组蛋白领域,谁能在抗原层面做的更好,并且可以联合新佐剂,尤其是自主研发的新佐剂,这样的公司是我们应该长期为伍的。</body></html>","text":"$瑞科生物-B(02179)$除了mRNA,还需要关注的是重组蛋白领域,谁能在抗原层面做的更好,并且可以联合新佐剂,尤其是自主研发的新佐剂,这样的公司是我们应该长期为伍的。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/616696275","repostId":0,"isVote":1,"tweetType":1,"viewCount":1670,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02179"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":151,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/616696275"}
精彩评论